Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (22)
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
Nonparametric Estimation from Incomplete Observations
1958 • 37,219 citations
Regression Models and Life-Tables
1992 • 27,454 citations
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
1959 • 14,850 citations
Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial
1975 • 2,224 citations
Indices of relative weight and obesity
1972 • 1,967 citations
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
1976 • 1,333 citations
EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON
1987 • 1,062 citations
L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast Cancer
1975 • 752 citations
The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer
1988 • 424 citations
Adjuvant Therapy of Cancer.
1978 • 325 citations
Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.
1986 • 215 citations
Histologic grading of breast cancer.
1980 • 177 citations
Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer.
1976 • 109 citations
Evaluation of tamoxifen dose in advanced breast cancer: a progress report.
1976 • 97 citations
Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
1976 • 73 citations
Current overview of EORTC clinical trials with tamoxifen.
1976 • 55 citations
REPEATED ADJUVANT CHEMOTHERAPY WITH PHENYLALANINE MUSTARD OR 5-FLUOROURACIL, CYCLOPHOSPHAMIDE, AND PREDNISONE WITH OR WITHOUT RADIATION, AFTER MASTECTOMY FOR BREAST CANCER
1978 • 52 citations
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
1985 • 43 citations
Antiestrogen-induced remissions in stage IV breast cancer.
1976 • 42 citations
Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer.
1988 • 42 citations
Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer.
1986 • 40 citations